• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白相关心脏淀粉样变:1例合并症患者的延迟诊断病例及文献综述

Transthyretin-Related Cardiac Amyloidosis: A Case of Delayed Diagnosis in the Comorbid Patient and Literature Review.

作者信息

Patel Akshaye, Stringer Immy, Edhem Leyan, Eni Gedoni, Delamere Rebecca, Ahmed Adnan, Solano Jhiamluka

机构信息

Internal Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Scunthorpe, GBR.

General Internal Medicine, Scunthorpe General Hospital, Scunthorpe, GBR.

出版信息

Cureus. 2025 Aug 11;17(8):e89851. doi: 10.7759/cureus.89851. eCollection 2025 Aug.

DOI:10.7759/cureus.89851
PMID:40951186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426968/
Abstract

We report the case of an 82-year-old male with a history of bronchiectasis, asthma, and atrial fibrillation, who presented with progressive exertional dyspnoea, peripheral oedema, and recurrent heart failure exacerbations. Initial management targeted presumed pulmonary decompensation. Elevated natriuretic peptides, echocardiographic evidence of concentric left ventricular hypertrophy with preserved ejection fraction, and progressive conduction abnormalities prompted further evaluation. A 99mTc-DPD scintigraphy scan revealed Perugini grade 3 myocardial uptake consistent with wild-type transthyretin (ATTRwt) cardiac amyloidosis. Serum and urine studies excluded light-chain amyloidosis. Despite the presence of classical 'red flag' features, including atrial fibrillation, carpal tunnel syndrome, and unexplained left ventricular hypertrophy, diagnosis was significantly delayed by approximately 18 months, from initial symptom onset to definitive diagnosis, during which recurrent hospitalisations and progressive functional decline occurred. Earlier features were overlooked due to the attribution of symptoms to coexistent pulmonary disease and chronic kidney dysfunction. This case highlights the diagnostic challenges posed by ATTRwt, particularly in multimorbid older adults. Overlapping features with respiratory and renal pathology, as well as age-associated cardiovascular changes, obscure the clinical picture. Awareness of hallmark extracardiac features, systematic use of cardiac imaging, and prompt nuclear scintigraphy are essential for timely diagnosis. Early identification may enable consideration of disease-modifying therapy and improved symptom management.

摘要

我们报告了一例82岁男性病例,该患者有支气管扩张、哮喘和心房颤动病史,表现为进行性劳力性呼吸困难、外周水肿和反复的心衰加重。初始治疗针对推测的肺功能失代偿。利钠肽升高、超声心动图显示射血分数保留的同心性左心室肥厚以及进行性传导异常促使进一步评估。99mTc-DPD闪烁扫描显示佩鲁吉尼3级心肌摄取,符合野生型转甲状腺素蛋白(ATTRwt)心脏淀粉样变性。血清和尿液检查排除了轻链淀粉样变性。尽管存在包括心房颤动、腕管综合征和不明原因的左心室肥厚等典型的“红旗”特征,但从最初症状出现到明确诊断,诊断显著延迟了约18个月,在此期间出现了反复住院和功能逐渐下降。由于将症状归因于并存的肺部疾病和慢性肾功能不全,早期特征被忽视。该病例突出了ATTRwt带来的诊断挑战,尤其是在患有多种疾病的老年人中。与呼吸和肾脏病理学的重叠特征,以及与年龄相关的心血管变化,使临床情况变得模糊。认识标志性的心外特征、系统使用心脏成像以及及时进行核闪烁扫描对于及时诊断至关重要。早期识别可能有助于考虑疾病修饰治疗并改善症状管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/2045d292cc21/cureus-0017-00000089851-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/f1bc3ab258c2/cureus-0017-00000089851-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/4b44d6053340/cureus-0017-00000089851-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/453508746f65/cureus-0017-00000089851-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/9a7e7b582b85/cureus-0017-00000089851-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/c80a8bda1048/cureus-0017-00000089851-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/a5eb71791286/cureus-0017-00000089851-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/2045d292cc21/cureus-0017-00000089851-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/f1bc3ab258c2/cureus-0017-00000089851-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/4b44d6053340/cureus-0017-00000089851-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/453508746f65/cureus-0017-00000089851-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/9a7e7b582b85/cureus-0017-00000089851-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/c80a8bda1048/cureus-0017-00000089851-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/a5eb71791286/cureus-0017-00000089851-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef31/12426968/2045d292cc21/cureus-0017-00000089851-i07.jpg

相似文献

1
Transthyretin-Related Cardiac Amyloidosis: A Case of Delayed Diagnosis in the Comorbid Patient and Literature Review.转甲状腺素蛋白相关心脏淀粉样变:1例合并症患者的延迟诊断病例及文献综述
Cureus. 2025 Aug 11;17(8):e89851. doi: 10.7759/cureus.89851. eCollection 2025 Aug.
2
Wild-Type Transthyretin Amyloid Depositions in the Subcutaneous Fat and Skeletal Muscles of a Nonagenarian Who Had Heart Failure With Preserved Ejection Fraction and No Myocardial Technetium-99m-Labeled Pyrophosphate Uptake.一位射血分数保留且无心肌99m锝标记焦磷酸盐摄取的老年心力衰竭患者皮下脂肪和骨骼肌中的野生型转甲状腺素蛋白淀粉样沉积。
Cureus. 2025 May 24;17(5):e84759. doi: 10.7759/cureus.84759. eCollection 2025 May.
3
A Challenging Case of Wild-Type Transthyretin Amyloidosis (ATTR) Amyloidosis Treated With Cardiac Resynchronization Therapy.1例具有挑战性的野生型转甲状腺素蛋白淀粉样变性(ATTR)淀粉样变性病例采用心脏再同步治疗。
Cureus. 2025 Jul 2;17(7):e87203. doi: 10.7759/cureus.87203. eCollection 2025 Jul.
4
Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review.野生型转甲状腺素蛋白淀粉样心肌病的疑诊、筛查和诊断:系统文献回顾。
ESC Heart Fail. 2022 Jun;9(3):1524-1541. doi: 10.1002/ehf2.13884. Epub 2022 Mar 27.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Assessment of ATTR Cardiac Amyloidosis in Patients with Left Ventricular Hypertrophy Using Tc-99m Pyrophosphate Scintigraphy.使用锝-99m焦磷酸盐闪烁扫描术评估左心室肥厚患者的转甲状腺素蛋白淀粉样变心肌病
Indian J Nucl Med. 2025 Mar-Apr;40(2):79-87. doi: 10.4103/ijnm.ijnm_156_24. Epub 2025 Jun 27.
7
Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis.系统性轻链(AL)淀粉样变性的非典型表现
Cureus. 2025 Jun 11;17(6):e85777. doi: 10.7759/cureus.85777. eCollection 2025 Jun.
8
Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF.循环细胞外基质蛋白 decorin 和 α-L-艾杜糖苷酸酶可区分野生型转甲状腺素蛋白心肌病变与野生型阴性的射血分数保留心衰/射血分数中间值心衰。
Cardiovasc Res. 2024 Nov 25;120(14):1727-1736. doi: 10.1093/cvr/cvae189.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Navigating Diagnostic Ambiguities in Cardiac Amyloidosis: Insights from a Case with Delayed Diagnosis of AL Amyloidosis.心脏淀粉样变性诊断中的模糊性解析:一例AL型淀粉样变性延迟诊断病例的启示
Am J Case Rep. 2025 Jul 4;26:e948092. doi: 10.12659/AJCR.948092.

本文引用的文献

1
Heart Failure with Preserved Ejection Fraction and Cardiac Amyloidosis in the Aging Heart.衰老心脏中的射血分数保留型心力衰竭和心脏淀粉样变性。
Int J Mol Sci. 2024 Oct 26;25(21):11519. doi: 10.3390/ijms252111519.
2
Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study.射血分数保留的心力衰竭患者中甲状腺素运载蛋白心脏淀粉样变的患病率:PRACTICA研究
Rev Esp Cardiol (Engl Ed). 2025 Apr;78(4):301-310. doi: 10.1016/j.rec.2024.07.005. Epub 2024 Jul 31.
3
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not.
心脏淀粉样变性中的心律失常负担:我们所知与未知
Biomedicines. 2022 Nov 10;10(11):2888. doi: 10.3390/biomedicines10112888.
4
Transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变性。
Cardiovasc Res. 2023 Feb 3;118(18):3517-3535. doi: 10.1093/cvr/cvac119.
5
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.轻链和转甲状腺素蛋白心脏淀粉样变性患者心脏起搏器植入的发生率和危险因素。
Eur J Heart Fail. 2022 Jul;24(7):1227-1236. doi: 10.1002/ejhf.2533. Epub 2022 May 16.
6
Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变性患者传导系统疾病的患病率、发病率及其对死亡率的影响。
Am J Cardiol. 2020 Aug 1;128:140-146. doi: 10.1016/j.amjcard.2020.05.021. Epub 2020 May 16.
7
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.心脏淀粉样变性:不断发展的诊断和治疗——美国心脏协会的科学声明。
Circulation. 2020 Jul 7;142(1):e7-e22. doi: 10.1161/CIR.0000000000000792. Epub 2020 Jun 1.
8
Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.心脏淀粉样变:被忽视、被低估且可治疗。
Annu Rev Med. 2020 Jan 27;71:203-219. doi: 10.1146/annurev-med-052918-020140.
9
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变性的超声心动图表型与预后
Eur Heart J. 2020 Apr 7;41(14):1439-1447. doi: 10.1093/eurheartj/ehz905.
10
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.心脏转甲状腺素蛋白淀粉样变性的自然病史、生活质量和结局。
Circulation. 2019 Jul 2;140(1):16-26. doi: 10.1161/CIRCULATIONAHA.118.038169. Epub 2019 May 21.